All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @broterotv_ on Instagram · 17s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @broterotv_'s video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Day one of taking 200 milligrams of testosterone day two of a three of day four
  2. 0:05This is day five a six day eight day eight of taking 200 milligrams of testosterone
  3. 0:12What do you think did I get any bigger?

@broterotv_'s testosterone dosing approach, fact-checked

Andres Brotero

Instagram creator

12.9K viewsView on Instagram

Quick answer

The creator is on a self-reported TRT protocol of 200mg testosterone weekly, split into two 100mg injections, with an IGF-1 of 91 ng/mL. They are documenting an eight-day visual assessment after a dose increase from 140mg to 200mg weekly. The clinical concern here is that dose escalation of this magnitude warrants monitoring for erythrocytosis, estradiol changes, and cardiovascular markers, none of which are addressed in the content.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @broterotv_'s testosterone dosing approach, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@broterotv_'s testosterone dosing approach, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@broterotv_'s testosterone dosing approach, fact-checked" from Andres Brotero. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is on a self-reported TRT protocol of 200mg testosterone weekly, split into two 100mg injections, with an IGF-1 of 91 ng/mL.

The reason this review is not generic is the source wording and the canonical claim label "trt 100mg twice a week monday and thursday so this was 4 weeks." In this clip, the useful excerpt is: "Day one of taking 200 milligrams of testosterone day two of a three of day four This is day five a six day eight day eight of taking 200 milligrams of testosterone What do you think did I get any bigger?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Any visual change visible within 8 days of a testosterone increase is almost certainly water retention or glycogen loading, not new muscle.
People who land here are usually comparing the Testosterone claim with testosterone, testosteronereplacement, and peptides.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is on a self-reported TRT protocol of 200mg testosterone weekly, split into two 100mg injections, with an IGF-1 of 91 ng/mL.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is on a self-reported TRT protocol of 200mg testosterone weekly, split into two 100mg injections, with an IGF-1 of 91 ng/mL. They are documenting an eight-day visual assessment after a dose increase from 140mg to 200mg weekly. The clinical concern here is that dose escalation of this magnitude warrants monitoring for erythrocytosis, estradiol changes, and cardiovascular markers, none of which are addressed in the content.
  • Bhasin et al. (2001, NEJM) showed testosterone-driven lean mass changes require weeks to months, not 8 days.
  • Any visual change visible within 8 days of a testosterone increase is almost certainly water retention or glycogen loading, not new muscle.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Bhasin et al. (2001, NEJM) showed testosterone-driven lean mass changes require weeks to months, not 8 days.
  • Any visual change visible within 8 days of a testosterone increase is almost certainly water retention or glycogen loading, not new muscle.
  • Splitting weekly testosterone into two injections does reduce serum level fluctuation, which is a pharmacologically reasonable practice.
  • A 43% dose increase (140mg to 200mg) raises estradiol conversion risk and requires monitoring for hematocrit, blood pressure, and lipids.
  • IGF-1 of 91 ng/mL is low-end normal for most adults, not uniformly deficient. Context like age and lab-specific ranges changes the interpretation significantly.
  • Pursuing IGF-1 increases through peptides is off-label territory that requires clinical supervision, not social media-based protocol design.
  • Storer et al. (2003, American Journal of Physiology) found dose-dependent lean mass changes over 20 weeks, reinforcing that short observation windows produce unreliable self-assessments.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @broterotv_ actually say?

The creator documented eight consecutive days on 200mg of testosterone and asked viewers directly: "did I get any bigger?" That is the core claim, framed as a visual progress check. The caption adds context: they moved from 140mg to 200mg weekly, split 100mg twice weekly on Mondays and Thursdays, and described this as four weeks of progression. They also mentioned chasing higher IGF-1 levels, currently sitting at 91 ng/mL, which they called "still so low."

So we have two things to fact-check: whether visible changes in eight days are plausible, and whether 91 ng/mL IGF-1 is genuinely low or just low-normal. Both are worth examining carefully before 12,900 viewers take notes.

Does the science back this up?

Not really, at least not for the eight-day visual change piece. Eight days is not enough time for meaningful hypertrophy, and testosterone does not work that fast on muscle tissue.

Bhasin et al. (2001, NEJM) remains one of the clearest dose-response studies on exogenous testosterone. Measurable lean mass gains required weeks to months, not days. The mechanism, which involves increased muscle protein synthesis and satellite cell activation, is a slow process. Water retention and glycogen loading can produce a "fuller" look within days, but that is not muscle and it reverses quickly.

On IGF-1: a result of 91 ng/mL in an adult male is on the lower end of most reference ranges, which typically run from roughly 88 to 246 ng/mL depending on age and lab. It is not dramatically deficient in most cases, but context matters. Testosterone does modestly raise IGF-1, largely through hepatic growth hormone sensitivity (Yarasheski et al., 1992, American Journal of Physiology).

What did they get wrong (or right)?

Credit where it is due: the Monday/Thursday split for 100mg doses is a reasonable protocol for maintaining steadier serum testosterone levels. Splitting weekly doses reduces peak-to-trough variation compared to a single weekly injection. That part is pharmacologically sound.

Where it gets murky is the framing. Asking "did I get any bigger" after eight days encourages viewers to look for visible changes that are almost certainly not muscle. If someone sees a difference, it is likely water and intramuscular glycogen, not new contractile tissue. That distinction matters if followers are adjusting their own protocols based on perceived eight-day results.

The IGF-1 discussion is underdeveloped. The creator flags 91 ng/mL as a problem without providing age, sex, or lab reference range. IGF-1 is not a standalone optimization target, and "increasing IGF" through peptides is a separate clinical conversation that belongs with a licensed provider, not an Instagram caption.

What should you actually know?

Eight days of testosterone will not build visible muscle. Full stop. The timeline for hypertrophy in response to androgen changes is measured in weeks to months, not single-digit days. Research from Storer et al. (2003, American Journal of Physiology) showed dose-dependent lean mass changes over 20 weeks, not 8 days.

Dose escalation from 140mg to 200mg weekly is a 43% increase. That is a meaningful jump. Higher doses carry higher aromatization risk (more testosterone converts to estradiol), increased red blood cell production, and cardiovascular strain over time. These are not trivial concerns and are not mentioned in the video.

IGF-1 optimization through peptides is a separate, off-label territory with its own risk profile. Anyone considering that path needs labs, a clinical workup, and a licensed provider, not a progression plan sourced from social media.

The bottom line

The creator is documenting their personal TRT experience, which is their right. But the implicit message, that you can assess testosterone-driven progress in eight days by looking in the mirror, is misleading and likely to produce bad decisions in viewers who are not working with a clinician. The dosing protocol mechanics are reasonable. The timeline expectations and the IGF-1 framing need serious correction.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Andres Brotero · Instagram creator

12.9K views on this video

100mg twice a week, Monday and Thursday! So this was 4 weeks of progression going from 140mg to 200mg Just got my labs again, going to attempt increasing my IGF…still so low 😫 at 91. #testosterone #t

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bhasin et al. (2001, nejm) showed testosterone-driven lean mass changes?

Bhasin et al. (2001, NEJM) showed testosterone-driven lean mass changes require weeks to months, not 8 days.

What does the video say about any visual change visible within 8 days of a testosterone?

Any visual change visible within 8 days of a testosterone increase is almost certainly water retention or glycogen loading, not new muscle.

What does the video say about splitting weekly testosterone into two injections does reduce serum level?

Splitting weekly testosterone into two injections does reduce serum level fluctuation, which is a pharmacologically reasonable practice.

What does the video say about a 43% dose increase (140mg to 200mg) raises estradiol conversion?

A 43% dose increase (140mg to 200mg) raises estradiol conversion risk and requires monitoring for hematocrit, blood pressure, and lipids.

What does the video say about igf-1 of 91 ng/ml?

IGF-1 of 91 ng/mL is low-end normal for most adults, not uniformly deficient. Context like age and lab-specific ranges changes the interpretation significantly.

What does the video say about pursuing igf-1 increases through peptides?

Pursuing IGF-1 increases through peptides is off-label territory that requires clinical supervision, not social media-based protocol design.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Andres Brotero, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.